Serum phosphorus concentrations and arterial stiffness among individuals with normal kidney function to moderate kidney disease in MESA
about
The role of phosphorus in the development and progression of vascular calcificationCalcium regulation and bone mineral metabolism in elderly patients with chronic kidney diseaseCardiovascular Risk Factors and Chronic Kidney Disease-FGF23: A Key Molecule in the Cardiovascular DiseaseThe Role of Emerging Risk Factors in Cardiovascular OutcomesPhosphate and cardiovascular diseaseAssociation of serum phosphorus with left ventricular mass in men and women with stable cardiovascular disease: data from the Heart and Soul Study.Dietary phosphorus, blood pressure, and incidence of hypertension in the atherosclerosis risk in communities study and the multi-ethnic study of atherosclerosisHypophosphatemic effect of niacin in patients without renal failure: a randomized trial.Markers of arterial stiffness in a sample of Lebanese subjects with Grade I essential hypertensionSerum phosphorus levels and the spectrum of ankle-brachial index in older men: the Osteoporotic Fractures in Men (MrOS) studyThe association of bone density and calcified atherosclerosis is stronger in women without dyslipidemia: the multi-ethnic study of atherosclerosis.Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism.Relation of serum phosphorus levels to ankle brachial pressure index (from the Third National Health and Nutrition Examination Survey)Effect of dietary phosphate intake on the circadian rhythm of serum phosphate concentrations in chronic kidney disease: a crossover studyAssociation of fibroblast growth factor-23 with arterial stiffness in the Multi-Ethnic Study of AtherosclerosisIncidence and progression of coronary calcification in chronic kidney disease: the Multi-Ethnic Study of Atherosclerosis.Association between circulating fibroblast growth factor 23, α-Klotho, and the left ventricular ejection fraction and left ventricular mass in cardiology inpatientsMarkers of mineral metabolism are not associated with aortic pulse wave velocity in community-living elderly persons: the Health Aging and Body Composition study.Effects of the Use of Non-Calcium Phosphate Binders in the Control and Outcome of Vascular Calcifications: A Review of Clinical Trials on CKD Patients.Relation of sex and estrogen therapy to serum fibroblast growth factor 23, serum phosphorus, and urine phosphorus: the Heart and Soul Study.Hyperphosphate-Induced Myocardial Hypertrophy through the GATA-4/NFAT-3 Signaling Pathway Is Attenuated by ERK Inhibitor Treatment.Cardiovascular risk factors in chronic kidney disease: does phosphate qualify?Survival in patients with poorly compressible leg arteries.Associations of socioeconomic status and processed food intake with serum phosphorus concentration in community-living adults: the Multi-Ethnic Study of Atherosclerosis (MESA).The Envy of Scholars: Applying the Lessons of the Framingham Heart Study to the Prevention of Chronic Kidney DiseaseDietary phosphorus intake and mortality in moderate chronic kidney disease: NHANES III.Associations of dietary phosphorus intake, urinary phosphate excretion, and fibroblast growth factor 23 with vascular stiffness in chronic kidney disease.Liver X receptor-activating ligands modulate renal and intestinal sodium-phosphate transporters.Arterial stiffness and bone demineralization: the Baltimore longitudinal study of aging.Hypophosphatemic effect of niacin extended release in ischemic kidney disease.Serum phosphorus and association with anemia among a large diverse population with and without chronic kidney disease.Relation of serum phosphorus levels to the incidence of atrial fibrillation (from the Atherosclerosis Risk In Communities [ARIC] study).Cardiovascular effects of sevelamer in stage 3 CKD.24-hour urine phosphorus excretion and mortality and cardiovascular events.Associations of estradiol and testosterone with serum phosphorus in older men: the Osteoporotic Fractures in Men study.Poststroke hip fracture: prevalence, clinical characteristics, mineral-bone metabolism, outcomes, and gaps in prevention.The connection between dietary phosphorus, cardiovascular disease, and mortality: where we stand and what we need to know.Peripheral vascular disease-related procedures in dialysis patients: predictors and prognosis.Effects of phosphate binder therapy on vascular stiffness in early-stage chronic kidney disease.Arterial stiffness in chronic kidney disease: the usefulness of a marker of vascular damage.
P2860
Q26823897-F55E02A3-5131-414D-9547-96AD23E2558FQ26863412-96E8A11D-B119-46BB-8328-8AAFF2E81425Q27024043-97E1D308-A80C-4258-A321-69FE7C97564CQ30234550-8594C8C9-4AD9-4FA8-9336-C4CCB5D7337BQ33566596-3027EF31-355F-4C60-9B81-4713E90043F1Q33617174-D2F513FF-45CE-4E6F-8CB2-BDAB2A0C5CABQ33672499-EA2F295F-E975-4774-8602-932033092237Q33770086-9984E0DD-1033-4C46-BB7C-ECF5F3A889A7Q33783539-3CFF22B2-6F8A-4B9B-A85C-7F0E2C03A350Q33880783-25849843-92ED-457E-B80B-75C2CCCA0A64Q33909059-652A6940-742A-46C1-B68B-867BD251940CQ33944788-5E9B60E0-EE4A-40B1-99D8-41CB57A6915EQ34146157-DDB16EAC-A244-4EBE-97A4-310B4659D777Q34336027-C628D8DC-8DBE-43B3-A051-6CEA9D0DECCEQ34406871-A28207B7-D1B3-49D0-8353-61032F610EADQ34576693-3D1B404A-C63C-4E1E-8111-6075A50AD994Q34988878-891A668D-51E7-47C8-BA50-66337A73FA52Q35053281-A494B721-45A3-4F10-9CC3-5036401F7508Q35055927-19918E48-4238-4E41-A96C-74E153DC5493Q35421211-E8F730FD-3E97-4BDD-89EA-C6FB36EB5AD1Q35592504-8D183214-B927-4CD5-9340-B66B65F5A386Q35679887-629B5698-4840-4AED-9F5E-7A6813E54645Q35838381-93B1D6C2-33F9-456F-9249-805D0E346950Q35875497-8D7F7027-EC63-4C0A-ADFB-88C417D47416Q35914820-C9300ED0-24DE-484D-8B53-A209CA6E9DA8Q35953344-61E7E422-FB36-4998-98EA-7F3D8D9D66E2Q36044367-47C21638-3685-4D2C-97DD-196411A342A5Q36191156-F7CB0C93-A484-4B07-A801-BB635118F00BQ36212522-779D1C04-0931-4A7C-AA03-999FCEDFC14BQ36606586-C8B951E4-11DB-4E27-8D0B-08AEC9B1B4E5Q36722347-F6024232-0544-4958-BBB1-A7552622288BQ36784276-3C58219E-22AE-4AE7-8157-6A8B711E781DQ36796599-4E0CCD5D-124B-4A4C-8F66-26BA482420EDQ36980376-B0C12014-8943-4F10-B36B-6FDB6A17DAB0Q37208969-BC8AC9BD-D2BB-4BBB-B522-D026674573BEQ37239835-88F00673-4131-4B49-9C86-16C253469A3BQ37296494-526F9A01-572D-4094-BB13-27DAC273D2E5Q37378441-CCC53AAE-4CFD-425B-A0B3-82F4F594F579Q37416887-86625163-FA36-4EBF-8446-E19E68C2147BQ37887526-6DCDE37C-18E6-48DB-A917-43F0230A3803
P2860
Serum phosphorus concentrations and arterial stiffness among individuals with normal kidney function to moderate kidney disease in MESA
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Serum phosphorus concentration ...... oderate kidney disease in MESA
@en
Serum phosphorus concentration ...... derate kidney disease in MESA.
@nl
type
label
Serum phosphorus concentration ...... oderate kidney disease in MESA
@en
Serum phosphorus concentration ...... derate kidney disease in MESA.
@nl
prefLabel
Serum phosphorus concentration ...... oderate kidney disease in MESA
@en
Serum phosphorus concentration ...... derate kidney disease in MESA.
@nl
P2093
P2860
P50
P356
P1476
Serum phosphorus concentration ...... oderate kidney disease in MESA
@en
P2093
Carmen A Peralta
Daniel A Duprez
Ian H De Boer
Kathryn L Adeney
Nancy S Jenny
P2860
P304
P356
10.2215/CJN.04100808
P577
2009-02-11T00:00:00Z